Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug;5(3):50-3.

Long term protection after hepatitis B vaccination

Sandra Puvacić  1 , Jelena Ravlija, Zlatko Puvacić, Ivan Curić
Affiliations

Long term protection after hepatitis B vaccination

Sandra Puvacić et al. Bosn J Basic Med Sci. 2005 Aug.

Abstract

A survey of persistence of anti-HBs after hepatitis B vaccination has shown that five years after vaccination on a sample of 152 persons, or 82.53%, stands at >10 IU/I. Long term immunogenicity of vaccinated children remained at 88.89%, health workers 79.41% and drug addicts 64.28%. The results of these studies in Bosnia and Herzegovina show the high level of protection hepatitis B vaccine against HBV infection. Vaccination against viral hepatitis B results in immunologic memory response among the vaccinated, and even after a decrease of anti-HB level following the third vaccine dose inoculation, a booster dose is not needed. Immunity remains steady and a booster dose is not recommended.

PubMed Disclaimer

References

    1. Mele A, Stroffolini T. Hepatitis B in Italy where we areten years after the introduction of mas vaccination. J. Med. Virol. 2002;67:440–43. - PubMed
    1. Dominguez A, Vidal J. Changesin the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine. 2000;18:23452350. - PubMed
    1. Faeh FZ, Ayoola EA. Seroepidemiologyof hepatitis B virus infection in Saudi Arabian children a baseline survey for mass vaccination against hepatitis. B.J. Infect. 1992;24:197–206. - PubMed
    1. Al-Faleh F.Z, Ramia S. Seroepidemiologyof hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect. 1999;38:167–170. - PubMed
    1. Lin Y.C, Chang M.H. Long-term immunogenicity and efficacy of universal hepatitis Bvirusvaccination in Taiwan. J. Infect. Dis. 2003;187:134–138. - PubMed

Substances

LinkOut - more resources